Clinical trials
Active, not recruiting Triple Negative Breast Neoplasms trials in Taiwan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 3 |
| 2019 | 4 |
| 2020 | 1 |
| 2022 | 3 |
| 2023 | 1 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 14 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 4 |
| AbbVie | 2 |
| Gilead Sciences | 2 |
| Novartis Pharmaceuticals | 2 |
| Alterome Therapeutics, Inc. | 1 |
| Arcus Biosciences, Inc. | 1 |
| OBI Pharma, Inc | 1 |
| Seagen, a wholly owned subsidiary of Pfizer | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Triple Negative Breast Neoplasms | 14 |
| Breast Neoplasms | 5 |
| Carcinoma, Non-Small-Cell Lung | 4 |
| Neoplasms | 4 |
| Ovarian Neoplasms | 3 |
| Squamous Cell Carcinoma of Head and Neck | 3 |
| Carcinoma, Renal Cell | 2 |
| Colorectal Neoplasms | 2 |
| Esophageal Neoplasms | 2 |
| Melanoma | 2 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.